SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-22-034045
Filing Date
2022-09-20
Accepted
2022-09-20 16:58:59
Documents
7

Document Format Files

Seq Description Document Type Size
1 425 brhc10042060_425.htm 425 64172
2 EXHIBIT 2.1 brhc10042060_ex2-1.htm EX-2.1 524525
3 EXHIBIT 99.1 brhc10042060_ex99-1.htm EX-99.1 55066
4 EXHIBIT 99.2 brhc10042060_ex99-2.htm EX-99.2 58618
5 EXHIBIT 99.3 brhc10042060_ex99-3.htm EX-99.3 29299
6 image0.jpg GRAPHIC 139472
7 image1.jpg GRAPHIC 7768
  Complete submission text file 0001140361-22-034045.txt   936592
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filed by) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 BROADWAY SUITE 310 CAMBRIDGE MA 02139
Business Address 201 BROADWAY SUITE 310 CAMBRIDGE MA 02139 610-424-2650
Renovacor, Inc. (Subject) CIK: 0001799850 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39271 | Film No.: 221254311
SIC: 2836 Biological Products, (No Diagnostic Substances)